Abstracts Archive - Page 2419 of 2607 - ACR Meeting Abstracts

Abstract Number: 119 • 2013 ACR/ARHP Annual Meeting
Routine Assessment Of Patient Index Data 3 In Fibromyalgia: A Rapid and Reliable Instrument For Evaluating Disease Severity?
Ece Kaptanoglu, Ozlem Sahin, Yunus Durmaz, Ahmet Kivanc Cengiz and Sami Hizmetli, Rheumatology, Cumhuriyet University, Sivas, Turkey
Background/Purpose: Routine Assessment of Patient Index Data 3 (RAPID 3) is a patient based questionnaire which was designed for evaluation of disease activity without formal…
Abstract Number: 100 • 2013 ACR/ARHP Annual Meeting
Myocardial Infarction and Mortality after Joint Surgery in Patients with Rheumatoid Arthritis Compared with the General Population
Joanne Tropea¹, Mark Tacey², Megan Bohensky², Caroline Brand², Ian Wicks³ and Sharon Van Doornum², ¹Melbourne EpiCentre, Royal Melbourne Hospital, Melbourne, Australia, ²Melbourne EpiCentre, The University of Melbourne, Melbourne, Australia, ³Rheumatology Unit, Royal Melbourne Hospital, Melbourne, Australia
Background/Purpose: Rheumatoid arthritis (RA) is associated with an increased risk of myocardial infarction (MI) and post-MI fatality compared with the general population. In a previous…
Abstract Number: 101 • 2013 ACR/ARHP Annual Meeting
Trends In Prescription Of Opioids From 2003-2009 In Persons With Knee Osteoarthritis
Elizabeth Wright¹, Jeffrey N. Katz², Stanley Abrams³, Daniel H. Solomon⁴ and Elena Losina⁵, ¹Orthopedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, ²Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA, ³Orthopedics and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, ⁴Division of Pharmacoepidemiology, Harvard Medical School, Brigham and Women's Hospital, Division of Rheumatology, Division of Pharmacoepidemiology, Boston, MA, ⁵Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Osteoarthritis (OA) of the knee is a painful condition affecting ~13% of persons >65 years of age. OA is often accompanied by comorbidities. Effective…
Abstract Number: 102 • 2013 ACR/ARHP Annual Meeting
Association Of Area-Level Socioeconomic Status With Pain and Function At Presentation For Total Knee Arthroplasty
Candace H. Feldman¹, Yan Dong², Jeffrey N. Katz³, Laurel Donnell-Fink⁴ and Elena Losina², ¹Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ²Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, ³Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA, ⁴Brigham and Women's Hospital, Boston, MA
Background/Purpose: Prior studies suggest that individuals with lower socioeconomic status (SES) both under-utilize joint replacement procedures and present with increased pain and poorer function. Area-level…
Abstract Number: 103 • 2013 ACR/ARHP Annual Meeting
Proportion Of U.S. Older Adults Meeting Inclusion Criteria For 2010 ACR Recommendations On Glucocorticoid-Induced Osteoporosis
Robert A. Overman^1,2, Joshua C. Toliver³, Jun-Yen Yeh⁴, Margaret L. Gourlay⁵ and Chad L. Deal⁶, ¹Eshelman School of Pharmacy - Division of Pharmaceutical Policy and Outcomes, University of North Carolina, Chapel Hill, NC, ²Rheumatology, Cleveland Clinic, Cleveland, OH, ³Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, ⁴Arnold & Marie Schwartz College of Pharmacy and Health Sciences - Divison of Pharmaceutical Sciences, Long Island University, Brooklyn, NY, ⁵Family Medicine, University of North Carolina, Chapel Hill, NC, ⁶Dept of Rheum & Imm Dis /A 50, Cleveland Clinic, Cleveland, OH
Background/Purpose: Glucocorticoid-induced osteoporosis (GIO) is the most common cause of secondary osteoporosis. Fracture related to GIO increases a patient’s mortality risk and reduces quality of…
Abstract Number: 104 • 2013 ACR/ARHP Annual Meeting
Incidence Of Osteoporotic Hip Fractures In Estonia Between 2005 and 2012
Mikk Jürisson^1,2, Anneli Uusküla¹, Riina Kallikorm³, Sigrid Vorobjov^2,4 and Margus Lember³, ¹Department of Public Health, Faculty of Medicine, Tartu University, Tartu, Estonia, ²East Tallinn Central Hospital, Tallinn, Estonia, ³Department of Internal Medicine, Faculty of Medicine, Tartu University, Tartu, Estonia, ⁴National Institute for Health Development, Tallinn, Estonia
Background/Purpose: Monitoring the incidence of hip fractures is essential to measuring population health and the value of improvements in health care. Data on recent trends…
Abstract Number: 105 • 2013 ACR/ARHP Annual Meeting
Medication Use With Denosumab (Prolia^®) In a Large Claims Database In The United States
Emily Durden¹, Lung-I Cheng², Elnara Eynullayeva³, Christopher Gregory³ and Bradley Stolshek², ¹Truven Health Analytics, Bethesda, MD, ²Amgen, Inc., Thousand Oaks, CA, ³Truven Health Analytics, Washington, DC
Background/Purpose: Persistence and compliance with osteoporosis therapies is associated with significantly fewer vertebral, nonvertebral and hip fractures. A number of studies have examined medication-taking behavior…
Abstract Number: 106 • 2013 ACR/ARHP Annual Meeting
Antinuclear Antibodies Positive But No Autoimmune Disease
M Herold¹ and Werner Klotz², ¹Internal Medicine VI, Medical University of Innsbruck, Innsbruck, Austria, ²Internal Medicine VI, Innsbruck Medical University, Innsbruck, Austria
Background/Purpose: Antinuclear antibodies (ANAs) are tested in sera of patients suspicious of an autoimmune disorder. ANAs are part in many classification criteria of autoimmune (AI)…
Abstract Number: 107 • 2013 ACR/ARHP Annual Meeting
Duration Of Symptoms Before Diagnosis In Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Merete Lund Hetland^1,2 and Jan Sørensen³, ¹The Danish Rheumatologic Database (DANBIO), Glostrup Hospital, Glostrup, Denmark, ²Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, The Danish Rheumatologic Database (DANBIO), Glostrup Hospital., Copenhagen, Denmark, ³Center for Applied Health Services Research, University of South Denmark, Odensen, Denmark
Background/Purpose: Early diagnosis is important for the treatment of many rheumatic diseases. Little is known about the duration of symptoms before establishment of diagnosis, and if the…
Abstract Number: 108 • 2013 ACR/ARHP Annual Meeting
Cost-Effectiveness Analysis Of Diagnostic Tests In The Work-Up Of Patients With Intermediate Risk Of Developing Rheumatoid Arthritis
Jolanda J. Luime¹, Maureen Rutten², Leander Buisman², Mark Oppe² and Johanna M.W. Hazes³, ¹Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands, ²Institute for Medical Technology Assessment, Erasmus University, Rotterdam, Netherlands, ³Rheumatology, Erasmus MC, Rotterdam, Netherlands
Background/Purpose: With technological improvements in genomics, cytomics and metabolomics many promising biomarkers for stratifying individuals at risk of developing Rheumatoid Arthritis will enter the market. …
Abstract Number: 109 • 2013 ACR/ARHP Annual Meeting
Comparison Of Characteristics In Rheumatoid Arthritis Between International and National Databases In Europe: A Systematic Literature Review
E. Gvozdenovic¹, R. Koevoets¹, J. Langenhoff², C.F. Allaart¹ and R. Landewe³, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Leiden University Medical Center, Leiden, Netherlands, ³Division of Clinical Immunology and Rheumatology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands
Background/Purpose: RA (Rheumatoid Arthritis) cohorts and registers are established for daily practice in clinical care. There are still differences between registries in disease activity and…
Abstract Number: 110 • 2013 ACR/ARHP Annual Meeting
Differing Disease Expression In Latin American Mestizo and Spanish Caucasian Patients With Rheumatoid Arthritis With The Same Access To Healthcare and Antirheumatic Treatment
Virginia Ruiz-Esquide¹, Sonia Cabrera², Julio Ramirez³, M. Victoria Hernández², José Inciarte¹, J. D. Cañete³ and Raimon Sanmarti², ¹Arthritis Unit. Rheumatology Service, Hospital Clinic of Barcelona, Barcelona, Spain, ²Arthritis Unit. Rheumatology Department, Hospital Clínic of Barcelona, Barcelona, Spain, ³Rheumatology, Hospital Clinic, Barcelona, Spain
Background/Purpose: Rheumatoid arthritis (RA) prevalence and clinical phenotype varies between ethnic groups. Few studies have analyzed differences in disease expression between Latin-Americans mestizos (LA) and…
Abstract Number: 111 • 2013 ACR/ARHP Annual Meeting
Identifying Groups At Increased Risk Of Developing Rheumatoid Arthritis Using Family History and Genetic Risk Scores
Jeffrey A. Sparks¹, Chia-Yen Chen², Xia Jiang³, Johan Askling⁴, Linda T. Hiraki⁵, Lars Klareskog⁶, Lars Alfredsson³, Karen H. Costenbader⁷ and Elizabeth W. Karlson¹, ¹Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ²Epidemiology, Harvard School of Public Health, Boston, MA, ³Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, ⁴Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden, ⁵Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard School of Public Health, Boston, MA, ⁶Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, ⁷Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Background/Purpose: The identification of high risk groups is crucial for RA prevention strategies. Individuals with family history (FH) of autoimmunity are at increased risk for…
Abstract Number: 112 • 2013 ACR/ARHP Annual Meeting
Sugar-Sweetened Soft Drink Consumption and Risk Of Developing Rheumatoid Arthritis In Women
Yang Hu¹, Karen H. Costenbader², Frank Hu³, Daniel H. Solomon⁴, Elizabeth W. Karlson² and Bing LU⁵, ¹Brigham and Women's Hospital, Boston, MA, ²Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ³Harvard School of Public Health, Boston, MA, ⁴Division of Pharmacoepidemiology, Harvard Medical School, Brigham and Women's Hospital, Division of Rheumatology, Division of Pharmacoepidemiology, Boston, MA, ⁵Rheumatology/Immunology, Brigham & Women's Hospital and Harvard Medical School, Boston, MA
Background/Purpose: Sugar-sweetened soft drink (SSSD) consumption is associated with weight gain, obesity, and increased risk of type 2 diabetes (T2DM) and cardiovascular disease (CVD). Previous…
Abstract Number: 113 • 2013 ACR/ARHP Annual Meeting
Posttraumatic Stress Disorder and Risk For Incident Rheumatoid Arthritis
Yvonne C. Lee¹, Susan Malspeis², Jessica Agnew-Blais³, Katherine Keyes⁴, Laura Kubzansky³, Andrea Roberts³, Karestan Koenen⁴ and Elizabeth Karlson⁵, ¹Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ²Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ³Harvard School of Public Health, Boston, MA, ⁴Columbia University Mailman School of Public Health, New York, NY, ⁵Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Woman's Hospital, Boston, MA
Background/Purpose: Posttraumatic stress disorder (PTSD) is associated with autoimmune dysfunction, but the relationship between PTSD and the incidence of autoimmune disorders has not been studied…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].